Sign up
Login
Friday 28th November 2025
13:45 Welcome and introduction (R. Stahel, S. Peters)
Early NSCLC (S. Peters)
14:00 Current recommendations for pathological workup and reflex testing (L. Bubendorf, Basel)
14:30 Role of immunotherapy in surgical stage II-III NSCLC (S. Peters, Lausanne)
15:00 Role of immunotherapy in unresectable stage III NSCLC (M. Pless, Winterthur)
15:30 Coffee break
SCLC (M. Pless)
16:00 Role of RT in SCLC (J. Willmann, Zürich)
16:30 Developments in frontline ED SCLC (M. Früh, St. Gallen)
17:00 Developments in late lines ED SCLC (M. Perol, Lyon)
Mesothelioma
17:30 All you need to know about mesothelioma (P. Baas, Leiden)
18:00 2 cases
18:30 Adjourn
Saturday 29th November 2025
Advanced AGA negative NSCLC (L. Mauti)
08:00 Development of ADCs in thoracic malignancies (D. Planchard, Paris)
08:30 Standards of care and prospects for IO in advance NSCLC (S. Rothschild, Baden)
09:00 other developments in precision oncology for advanced NSCLC (O. Gautschi, Luzern)
09:30 2 cases
10:00 Coffee break
Pulmonology (O. Gautschi)
10:30 Any progress in screening for NSCLC in 2024? (C. Von Garnier, Lausanne)
10:50 Research projects and vision of SAKK lung group 2026 (A. Curioni, Fribourg)
Oncogene Addiction (S. Peters)
11:10 Targeting EGFR (A. Passaro, Milano)
11:30 Targeting ALK (L. Mauti, Winterthur)
11:50 Other selected developments in targeted therapies (A. Addeo, Genève)
12:10 Result of the best case presentation / Wrap up (R. Stahel, Zürich)
12:15 End